Triple

T2664431
Position Surface form Disambiguated ID Type / Status
Subject Yellow Card Scheme E55600 entity
Predicate administeredBy P86 FINISHED
Object Medicines and Healthcare products Regulatory Agency E10163 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Medicines and Healthcare products Regulatory Agency | Statement: [Yellow Card Scheme, administeredBy, Medicines and Healthcare products Regulatory Agency]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: Medicines and Healthcare products Regulatory Agency
Context triple: [Yellow Card Scheme, administeredBy, Medicines and Healthcare products Regulatory Agency]
  • A. UK Medicines and Healthcare products Regulatory Agency chosen
    The UK Medicines and Healthcare products Regulatory Agency is the United Kingdom’s national authority responsible for regulating medicines, medical devices, and healthcare products to ensure their safety, quality, and effectiveness.
  • B. Committee for Proprietary Medicinal Products
    The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
  • C. Committee for Medicinal Products for Human Use
    The Committee for Medicinal Products for Human Use is the European Medicines Agency’s expert body responsible for evaluating and providing scientific opinions on the safety, quality, and efficacy of medicines for human use in the European Union.
  • D. European Medicines Agency
    The European Medicines Agency is the European Union’s regulatory authority responsible for the scientific evaluation, supervision, and safety monitoring of medicines for human and veterinary use.
  • E. European Directorate for the Quality of Medicines & HealthCare
    The European Directorate for the Quality of Medicines & HealthCare is a Council of Europe body responsible for developing quality standards and guidance to ensure the safety and efficacy of medicines and improve healthcare across member states.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69ab49e54de48190be708cd1cf8be073 completed March 6, 2026, 9:40 p.m.
NER Named-entity recognition batch_69abd96dba44819085c3e651afba7806 completed March 7, 2026, 7:53 a.m.
NED1 Entity disambiguation (via context triple) batch_69afaf5115648190bf1c66882410642d completed March 10, 2026, 5:42 a.m.
Created at: March 6, 2026, 9:54 p.m.